Mar 30, 2016 11:40 am UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, March 30, 2016 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that the U.S. Food and Drug...
Mar 30, 2016 11:35 am UTC| Business
Dublin, March 30, 2016 -- Research and Markets has announced the addition of the "Global Flexible Displays Market Analysis Trends - Industry Forecast to 2025" report to their offering. ...
Affimed Reports Financial Results for Fourth Quarter and Year End 2015
Mar 30, 2016 11:30 am UTC| Business
HEIDELBERG, Germany, March 30, 2016 -- Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial results...
Mar 30, 2016 11:30 am UTC| Business
BEDFORD, Mass., March 30, 2016 -- ConforMIS, Inc., a medical technology company that offers joint replacement implants customized to fit each patient's unique anatomy, today announced results from multiple clinical...
Mar 30, 2016 11:30 am UTC| Business
BARCELONA, Spain and NEW YORK, March 30, 2016 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a public biotechnology company advancing a new class of oral biologic therapeutics for addressing the gut microbiome and new...
Xtant Medical Announces FDA Clearance of the Xspan™ Laminoplasty Fixation System
Mar 30, 2016 11:30 am UTC| Business
BELGRADE, Mont., March 30, 2016 -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary,...
Provision Interactive Announces New Patent Applications
Mar 30, 2016 11:30 am UTC| Business
CHATSWORTH, Calif., March 30, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO), announced today that it is preparing five new patent applications on...